Publication: TRPC5-eNOS axis negatively regulates ATP-induced cardiomyocyte hypertrophy
Issued Date
2018-05-22
Resource Type
ISSN
16639812
Other identifier(s)
2-s2.0-85047409869
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Frontiers in Pharmacology. Vol.9, No.MAY (2018)
Suggested Citation
Caroline Sunggip, Kakeru Shimoda, Sayaka Oda, Tomohiro Tanaka, Kazuhiro Nishiyama, Supachoke Mangmool, Akiyuki Nishimura, Takuro Numaga-Tomita, Motohiro Nishida TRPC5-eNOS axis negatively regulates ATP-induced cardiomyocyte hypertrophy. Frontiers in Pharmacology. Vol.9, No.MAY (2018). doi:10.3389/fphar.2018.00523 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/46663
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
TRPC5-eNOS axis negatively regulates ATP-induced cardiomyocyte hypertrophy
Abstract
© 2018 Sunggip, Shimoda, Oda, Tanaka, Nishiyama, Mangmool, Nishimura, Numaga-Tomita and Nishida. Cardiac hypertrophy, induced by neurohumoral factors, including angiotensin II and endothelin-1, is a major predisposing factor for heart failure. These ligands can induce hypertrophic growth of neonatal rat cardiomyocytes (NRCMs) mainly through Ca2+-dependent calcineurin/nuclear factor of activated T cell (NFAT) signaling pathways activated by diacylglycerol-activated transient receptor potential canonical 3 and 6 (TRPC3/6) heteromultimer channels. Although extracellular nucleotide, adenosine 5'-triphosphate (ATP), is also known as most potent Ca2+-mobilizing ligand that acts on purinergic receptors, ATP never induces cardiomyocyte hypertrophy. Here we show that ATP-induced production of nitric oxide (NO) negatively regulates hypertrophic signaling mediated by TRPC3/6 channels in NRCMs. Pharmacological inhibition of NO synthase (NOS) potentiated ATP-induced increases in NFAT activity, protein synthesis, and transcriptional activity of brain natriuretic peptide. ATP significantly increased NO production and protein kinase G (PKG) activity compared to angiotensin II and endothelin-1. We found that ATP-induced Ca2+ signaling requires inositol 1,4,5-trisphosphate (IP3) receptor activation. Interestingly, inhibition of TRPC5, but not TRPC6 attenuated ATP-induced activation of Ca2+/NFAT-dependent signaling. As inhibition of TRPC5 attenuates ATP-stimulated NOS activation, these results suggest that NO-cGMP-PKG axis activated by IP3-mediated TRPC5 channels underlies negative regulation of TRPC3/6-dependent hypertrophic signaling induced by ATP stimulation.